For research use only. Not for therapeutic Use.
Elipovimab is a potent broadly neutralizing HIV-1 antibody for the targeted elimination of HIV-infected cells[1]
| Catalog Number | I041523 |
| CAS Number | 2101210-43-7 |
| Purity | ≥95% |
| Reference | [1]. Caroline Thue Hvilsom, et al. TLR-Agonist Mediated Enhancement of Antibody-Dependent Effector Functions as Strategy For an HIV-1 Cure. Front Immunol. 2021 Sep 23;12:704617. |
